Investigation of epiphora caused by rebamipide eyedrop

Investigation of epiphora caused by rebamipide eyedrop - Investigation of epiphora caused by rebamipide eyedrop

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016841

Enrollment

100

Registered

2015-04-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epiphora

Interventions

lacrimal surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients prescribed rebamipide eyedrop

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The probability of the epiphora caused by rebamipide eyedrop.	—

Secondary

Measure	Time frame
The cure rate of lacrimal treatment for epiphora.	—

Countries

Japan

Contacts

Public ContactHitoshi Imamura

Tsukazaki Hospital Ophthalmology

h.imamura@tsukazaki-eye.net079-272-8555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026